Health
Inhaled steroids reduce SARS-CoV-2-related genes in COPD – News-Medical.Net
A new study published on the preprint server medRxiv* aims to explore the effects of treatment with ICS on the expression of specific genes related to SARS-CoV-2 infection in bronchial epithelial cells in a prospective interventional design.
The chronic lung condition called COPD (chronic obstructive pulmonary disease) increases the risk of severe COVID-19.
Inhaled corticosteroids (ICS) are commonly prescribed to stabilize respiratory function in these patients, but the associated risk of bacterial infection has daunted some healthcare professionals from using them. Moreover, in vitro, studies show that they have an immunosuppressive effect on cells exposed to viruses. There is no evidence to reveal the effects of ICS on either sus…
-
General19 hours agoCarrie Bickmore named Victorian Australian of the Year for work to progress brain cancer research
-
Noosa News23 hours agoToddler dies after vehicle accident on rural property in Abergowrie
-
Noosa News23 hours agoMale nurse charged with raping two elderly women at Greenslopes hospital
-
Business24 hours agoHow to turn small ASX share investments into major long-term wealth